<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00222040</url>
  </required_header>
  <id_info>
    <org_study_id>0302208</org_study_id>
    <nct_id>NCT00222040</nct_id>
  </id_info>
  <brief_title>Microbubbles and Ultrasound in Stroke Trial: MUST Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether transcranial 2-MHz ultrasound combined with intravenous administration
      of microbubbles improves early recanalization in patients with acute ischemic stroke caused
      by middle cerebral artery (MCA) proximal occlusion treated with intravenous alteplase within
      3 hours of symptom onset.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Proximal MCA occlusion is recognized using MR or CT angiography performed before inclusion.
      All patients are treated with alteplase according to current guidelines. In addition,
      patients randomized in the active group are continuously exposed to transcranial 2-MHz
      ultrasound for 1 hour combined with intravenous administration of microbubbles. Controls are
      only treated with alteplase. The ultrasound beam is positioned at the thrombus/blood flow
      interface using color-coded sonography. Galactose-based microbubbles are administered via
      continuous intravenous infusion over 40 min.

      Early recanalization is assessed using MR or CT angiography 4 to 8 hours after symptom onset.
      The evaluation of angiograms is performed by 2 neuroradiologists blinded to group of
      randomization and clinical details. The primary outcome measure is the rate of early
      recanalization. Recanalization is assessed using the TIMI classification. Secondary endpoints
      include the rate of symptomatic intracerebral hemorrhage, mortality, and functional outcome
      on the modified Rankin scale at 3 months.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>June 2004</start_date>
  <completion_date type="Actual">June 2004</completion_date>
  <primary_completion_date type="Actual">June 2004</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of early recanalization on post-treatment MR or CT angiography. Recanalization is described using the tIMI classification.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of symptomatic intracerebral hemorrhage, mortality, Score on the modified Rankin scale</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Acute Ischemic Stroke</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Levovist</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No specific intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>2-MHz, low intensity transcranial ultrasound</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Levovist</intervention_name>
    <description>D-Galactose and palmitic palmitique intravenous 4 g</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute ischemic stroke

          -  MCA proximal occlusion on CT or MR angiography

          -  Thrombolysis with intravenous alteplase initiated within 3 hours of stroke onset
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>LARRUE Vincent, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Toulouse, FRANCE</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service de Neurologie</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie, Hôpital Gui de Chauliac</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie, Hôpital Sainte Anne</name>
      <address>
        <city>Paris</city>
        <zip>75674</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie Vasculaire, University Hospital</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Neurologie, University Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.strokecenter.org/trials/TrialDetail.aspx?tid=574</url>
  </link>
  <reference>
    <citation>Cintas P, Le Traon AP, Larrue V. High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug. Stroke. 2002 Feb;33(2):626-8.</citation>
    <PMID>11823681</PMID>
  </reference>
  <reference>
    <citation>Cintas P, Nguyen F, Boneu B, Larrue V. Enhancement of enzymatic fibrinolysis with 2-MHz ultrasound and microbubbles. J Thromb Haemost. 2004 Jul;2(7):1163-6.</citation>
    <PMID>15219200</PMID>
  </reference>
  <reference>
    <citation>Viguier A, Petit R, Rigal M, Cintas P, Larrue V. Continuous monitoring of middle cerebral artery recanalization with transcranial color-coded sonography and Levovist. J Thromb Thrombolysis. 2005 Feb;19(1):55-9.</citation>
    <PMID>15976968</PMID>
  </reference>
  <verification_date>June 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 15, 2005</study_first_submitted>
  <study_first_submitted_qc>September 15, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 22, 2005</study_first_posted>
  <last_update_submitted>April 29, 2010</last_update_submitted>
  <last_update_submitted_qc>April 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>LLAU Marie-Elise</name_title>
    <organization>University Hospital Toulouse</organization>
  </responsible_party>
  <keyword>Stroke</keyword>
  <keyword>thrombolysis</keyword>
  <keyword>ultrasound</keyword>
  <keyword>microbubbles</keyword>
  <keyword>alteplase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

